The 19 Largest German Companies By Market Capitalization

German equities declined swiftly in recent weeks due to the slowing economic growth in China.However some of the concerns regarding China’s impact on German firms may be over-estimated by investors.

From an article in the WSJ last month:

The DAX has had a wild ride this year. It was up 26.2% by April 10, but by Monday’s close the index had given up all its gains and more, falling into the red. Even after Tuesday’s rally, spurred on by a Chinese rate cut, it was lagging many European peers on a year-to-date basis, up 3.2%.

Germany’s economy expanded 0.3% in the first quarter from a quarter earlier and 0.4% in the second. The apparent inability of the economy to accelerate much could be cause for concern in an environment of weaker global growth, particularly given Germany’s export franchise. But there are reasons to believe that Germany can rely on domestic support.

German export countries 2014

True, in the second quarter, German exports provided the biggest growth impetus, figures published Tuesday show. And in 2014, China was Germany’s fourth-biggest export market, accounting for EUR74.5 billion of German exports. That is equivalent to 6.6% of total exports, or 2.6% of German gross domestic product.

But the rest of the eurozone, U.S. and U.K., where growth has picked up, account for 52.6% of exports. While some 25% of exports do go to emerging markets, according to Berenberg, slower growth in these nations isn’t a new phenomenon, even if markets are only now panicking about it; Germany has kept its head above water. Eastern European countries, like Poland, Hungary and the Czech Republic, where Germany has major export exposures, are proving resilient.

Source: Germany’s Fate Doesn’t Depend on China, WSJ

The following chart shows the major trading partners in 2014:

Click to enlarge

Germany - Trading Partners 2014

Source; De Statis

Though China is the 4th largest export market for Germany, it is the 2nd top source of imports for Germany.

For investors looking to gain exposure to German equities, one way is to invest in the largest firms. In order to identify such companies I referred to the Financial Times FT Global 500 2015 list. The German firms appearing the list are shown below: 

FT Global 500 2015 - RankCompanyMarket value $m (as of Mar, 2015)Sector
49Volkswagen124,335.3Automobiles & parts
50Bayer124,157.7Chemicals
74Daimler103,741.0Automobiles & parts
87Basf91,489.5Chemicals
90Siemens90,196.5General industrials
92SAP88,793.3Software & computer services
98Deutsche Telekom83,314.0Mobile telecommunications
103BMW80,263.3Automobiles & parts
106Allianz79,417.8Nonlife insurance
200Henkel48,145.6Chemicals
203Deutsche Bank47,978.8Banks
208Continental47,106.4Automobiles & parts
282Deutsche Post37,852.2Industrial transportation
285Linde37,787.2Chemicals
294Munich Re37,258.2Nonlife insurance
383Fresenius30,129.9Health care equipment & services
390E On29,817.3Gas, water & multiutilities
478Fresenius Medical Care25,800.0Health care equipment & services

Source: FT

Investors with a long-term horizon can consider adding stocks such as Fresenius Medical Care AG & Co.(FMS), Allianz(AZSEY), Continental(CTTAY) and Henkel (HENKY) in a phased manner.

Disclosure: Long E.ON

Knowledge is Power Special: Hammurabi’s Code, Circus of Innovation, Trading Places Edition

  1. Socialism in America — Crooked Timber
  2. Rio: Brazil’s silicon beach | World news | The Observer
  3. Stumbling and Mumbling: Who benefits from benefits?
  4. The great corporate cash-hoarding crisis | Al Jazeera America
  5. America dumbs down: a rising tide of anti-intellectual thinking
  6. Uwe E. Reinhardt – Economix Blog – NYTimes.com
  7. China’s latest scandal is counterfeit condoms – Los Angeles Times
  8. Can businessmen make good politicians? | Business Line
  9. Brutal competition batters supermarkets the world over, The Guardian
  10. US Health Care System Cartel… Until Death Us Do Part | Common Dreams 
  11. Elizabeth Warren on factors ailing the middle class | Juggling Dynamite
  12. America’s Middle Class: From Boom to Bust – News – Politics – Voice of Russia – US Edition
  13. Ruth Whippman: How Corporate America Is Turning Into a Cult and Why It’s Harming the American Employee
  14. Uwe E. Reinhardt: Americans Are Shocked, Just Shocked, Over Hospital Bills – NYTimes.com
  15. Comparing Health Systems – UK NHS Performance | The Nuffield Trust
  16. A public option for banking | Al Jazeera America
  17. America’s Long and Productive History of Class Warfare – Justin Fox – Harvard Business Review
  18. The Fallacy of Financial Education | The Baseline Scenario
  19. 401ks Are Not Broken, You Are | The Big Picture
  20. Why Are Wages Sticky? | Uneasy Money
  21. Silicon Valley’s circus of innovation – Venkatesh Rao – Aeon
  22. America’s Workers: Stressed Out, Overwhelmed, Totally Exhausted – Rebecca J. Rosen – The Atlantic
  23. BBC News – American Dream breeds shame and blame for job seekers
  24. Our health spending problem is all about prices – These 15 charts show our health care prices are totally insane – Vox
  25. America’s greatest export is its debt – The Week
  26. How have these corporations colonised our public life? | George Monbiot | Comment is free | The Guardian
  27. The Price Of Human Life, According To GM | Common Dreams
  28. Millions see no benefit from soaring stock prices 
  29. Field of Schemes | sports stadium news and analysis
  30. Low-cost airlines have come a long way. But who will win the battle? – Telegraph
  31. ‘Worldly life is frightening:’ Famous Siberian hermit prefers taiga to civilization — RT News
  32. Articles: Psychopaths-in-Chief
  33. Waste vs. Value in American Health Care – NYTimes.com
  34. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America – Institute of Medicine
  35. Special Delivery: The Postal Service Story : All Songs Considered : NPR
  36. Why don’t Chinese spend more money? – The Curious Capitalist – TIME.com
  37. How the Maker of TurboTax Fought Free, Simple Tax Filing – ProPublica
  38. Uwe E. Reinhardt: Hammurabi’s Code and U.S. Health Care – NYTimes.com
  39. As Immigrants Move In, Americans Move Up | Daniel Griswold | Cato Institute: Free Trade Bulletin
  40. The era of the textbook cartel and $300 textbooks is ending | AEIdeas
  41. The Quiet Collapse of the Italian Economy | Euro Crisis in the Press
  42. Why Italy will not make it | Euro Crisis in the Press
  43. Why Canada’s inland shipping industry is making a major comeback | Financial Post
  44. The real story of US coal: inside the world’s biggest coalmine | Environment | The Guardian
  45. Business-Managed Culture – Business Values – Share Holding – Shares vs Public Ownership
  46. The Overwhelming Case against Capital Gains Taxation | International Liberty
  47. Too many choices, high costs and bureaucracy: British expats grade American healthcare system ‘a pain in the arse’ | Money | The Guardian
  48. Investment Riches Built on Subprime Auto Loans to Poor – NYTimes.com
  49. How Many Americans Have A Passport? | TheExpeditioner Travel Site
  50. Federal Spending: Where Does the Money Go
  51. America’s Incredible Shrinking Stock Market | Canadian Investment Review
  52. Investment Strategies for Volatile Markets – Fidelity
  53. Don’t Even Think About Trading Places in Markets – Bloomberg View

Sears Tower, Chicago

Sears Tower, Chicago

How Champagne is Made

Here is a cool infographic on how champagne is made:

Click to enlarge

How Champagne is Made

According to the legend, champagne was invented on August 4, 1693 by a Benedictine monk Dom Perignon who at the time served as cellar master of the Abbey of Hautvillers. “Come quickly! I’m drinking the stars!” he exclaimed when tasting wine that he was unable to rid of bubbles, and thus the legendary beverage was born.

Source: Sputnik News

Six Facts About DAX

Germany’s benchmark DAX Index has been swinging wildly in the past few weeks like an emerging market index such as the Bovespa or Sensex. I haven’t seen DAX so volatile in the past. However times have changed. The DAX has become highly volatile among major global developed indices since China’s economy is in a slowdown and many of the DAX constituents generate a substantial portion of their revenue from the communist country.

The DAX is up by 2.4% year-to-date. Currently it is at 10,038. In the past few 52-week it reached as high as 12374. From being one of the best performers this year the index has given up most of the gains and is up marginally now.

The DAX 1-year return chart is shown below:

Click to enlarge

DAX 1 year-return

The DAX long-term return chart is shown below:

DAX Long-tem-returns

Source: ComDirect

Though the short-term chart shows high volatility in the long-term DAX has grown nicely.

Here are a few interesting facts about DAX:

  1. The Base Date for DAX is 30 December 1987 and the base level is 1,000 points.
  2. The index represents the largest blue-chip German firms.
  3. DAX is weighted by market capitalization, i.e. the weighting of a single stock relates to its share in the overall capitalization of the stocks contained in the index. The return reported is the total-return which means it includes price appreciation and dividends. This is a BIG difference between DAX and other indices such as the S&P 500, FTSE 100, CAC-40, etc. which do not include dividends in their calculations.
  4. The components of the DAX has changed over the years as a reflection of the development of major German companies in the economy. When it was launched in 1988, the original constituents were: Allianz, BASF, Bayer, Bayerische Hypotheken- und Wechselbank, Bayerische Vereinsbank, BMW, Commerzbank, Continental, Daimler-Benz, Degussa, Deutsche Bank, Deutsche Babcock, Deutsche Lufthansa, Dresdner Bank, Feldmühle Nobel, Henkel, Hoechst, Karstadt, Kaufhof, Linde, MAN, Mannesmann, Nixdorf, RWE, Schering, Siemens, Thyssen, Veba, Viag, Volkswagen.
  5. Today’s DAX does not include firms like MAN, Mannesmann, Veba, Viag, etc. due to mergers, takeovers, bankruptcies, etc. The current components of the index can be found here.
  6. Reflecting the composition of the German economy, the top sectors represented in the index are Chemicals, Automobiles & Parts, Industrials and Pharma & Healthcare.

Source: 25 YEARS OF THE DAX® – THE FACTS, Deutsche Boerse

Related ETF:

  • iShares MSCI Germany (EWG)

Disclosure: No Positions

The Top Five Biotech Companies By Market Capitalization

Biotech stocks have been red hot in the past few years and they continue to attract investors’ attention this year as well. So far this year the NYSE Arca Biotech index is up by 9.2 compared to the 6.7% fall of S&P 500.

Many of the biotechs currently trading on the markets do not have proven drugs but rather are working on cures for many diseases including cancer. Only a handful of biotechs succeed and the rest usually disappear after a few years. Hence investing in this sector is not for all investors. In fact, investing in most of these companies can be considered speculative investments since nobody knows what which company will succeed and which ones will fail. Investors are simply betting that their company will discover the next big thing.

Currently over 150 biotechs trade on the NASDAQ. New companies including European firms went public in the past few months though the pace has declined due to the current market conditions.

The largest biotech ETF iShares Trust – iShares Nasdaq Biotechnology ETF (IBB) has shot up by over 298% in the past five years. A hypotectical growth of $10,000 (with reinvestment of dividends and capital gains) is shown in the chart below:

Click to enlarge

IBB Return 5 Years

Source: iShares

The five largest biotechs by market value are listed below with their current market cap and dividend yields. These are also in top 10 holdings of the above ETF and these account for over 40% of the portfolio weight:

1.Company: Celgene Corp (CELG)
Current Dividend Yield: No dividends paid
Market Cap: $92.8 Billion

2.Company: Amgen Inc (AMGN)
Current Dividend Yield: 2.15%
Market Cap: $111.5 Billion

3.Company: Gilead Sciences Inc (GILD)
Current Dividend Yield: 1.69%
Market Cap: $149.8 Billion

4.Company: Biogen Inc (BIIB)
Current Dividend Yield: No dividends paid
Market Cap: $71.1 Billion

5.Company: Regeneron Pharmaceuticals Inc (REGN)
Current Dividend Yield: No dividends paid
Market Cap: $51.8 Billion

Note: Dividend yields noted above are as of Sept 4, 2015. Data is known to be accurate from sources used.Please use your own due diligence before making any investment decisions.

Disclosure: No Positions